Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5363358 | 0.80 | ALDH1A1 (0.46) | POLBMAPTLMNAALOX15TSHR | |
| SCHEMBL5361049 | 0.79 | LMNA (0.50) | POLBMAPTLMNATSHRSMN1; SMN2 | |
| SCHEMBL6315459 | 0.77 | L3MBTL1 (0.38) | POLBMAPTTP53LMNAALOX15 | |
| SCHEMBL5359433 | 0.70 | POLB (0.37) | POLBMAPTLMNAALDH1A1 | |
| SCHEMBL5361045 | 0.70 | ALDH1A1 (0.43) | POLBMAPTLMNASMN1; SMN2KDM4E | |
| SCHEMBL6061529 | 0.69 | PDE4D (0.40) | POLBALOX15SMN1; SMN2GAAALDH1A1 | |
| SCHEMBL7126888 | 0.68 | MAPT (0.40) | POLBMAPTTP53THRBTDP1 | |
| SCHEMBL6061127 | 0.67 | HMGCR (0.36) | MAPTGAA | |
| SCHEMBL6309420 | 0.66 | L3MBTL1 (0.40) | POLBMAPTTP53LMNAALOX15 | |
| SCHEMBL5665366 | 0.66 | L3MBTL1 (0.52) | POLBMAPTLMNASMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7208481-B2 | Aminodiphosphonate apolipoprotein E modulators | ILEX PRODUCTS, INC. (US) | 2007-04-24 | — | — | US | claimed |
| US-20050075317-A1 | Aminodiphosphonate apolipoprotein e modulators | PHAN HIEU TRUNG (CH) | 2005-04-07 | — | — | US | claimed |
| EP-1482897-A2 | AMINODIPHOSPHONATE APOLIPOPROTEIN E MODULATORS | Ilex Products, Inc. (US) | 2004-12-08 | — | — | EP | claimed |
| WO-2003070169-A2 | AMINODIPHOSPHONATE APOLIPOPROTEIN E MODULATORS | ILEX PRODUCTS, INC. (US) | 2003-08-28 | — | — | WO | claimed |
| US-7208481-B2 | Aminodiphosphonate apolipoprotein E modulators | ILEX PRODUCTS, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-20050075317-A1 | Aminodiphosphonate apolipoprotein e modulators | PHAN HIEU TRUNG (CH) | 2005-04-07 | — | — | US | disclosed |
| EP-1482897-A2 | AMINODIPHOSPHONATE APOLIPOPROTEIN E MODULATORS | Ilex Products, Inc. (US) | 2004-12-08 | — | — | EP | disclosed |
| WO-2003070169-A2 | AMINODIPHOSPHONATE APOLIPOPROTEIN E MODULATORS | ILEX PRODUCTS, INC. (US) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075317-A1 | Aminodiphosphonate apolipoprotein e modulators | APOB, APOL1, NAPEPLD | POLB 2745/4885MAPT 1389/4885TP53 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.